From southeast China, Dr. Xue Hao, a postdoctoral research fellow in the Rugang Zhang lab at The Wistar Institute, is tackling ovarian cancer. With a degree in Applied Chemistry from Nanjing Agricu…
Think tank Heartland Forward released a new report tracking technology transfers from research institutions that lead to innovations that build stronger economies and The Wistar Institute ranked 3r…
Wistar offers the perfect blend of qualities for cancer researchers to thrive. Challenging science paired with a social cause is the winning formula that propels Dr. Maureen Murphy in her quest to …
Dr. Jason Diaz, The Wistar Institute education program director, moved around R.W. Brown Community Center classroom full of aquariums with turtles and fish, assorted plants, and books. Dr. Diaz’s e…
Researchers in the Weiner Lab developed DNA-launched bispecific T cell engagers that controlled tumor growth and improved survival in glioblastoma. Glioblastoma is one of the most severe and aggres…
A decade-long collaboration between Wistar and ChristianaCare is leading to new discoveries and better treatment for triple-negative breast cancer patients. Dario C. Altieri, M.D., president, CEO, …
Nestled in Northern Italy, the city of Bologna is one filled with medieval architecture, sprawling city squares, and a culture of scientific excellence. The University of Bologna is considered the …
This National Postdoc Appreciation Week, we asked our postdoctoral fellows how they strive to keep balance between their research and personal lives. Wistar postdoctoral fellows serve as critical m…
As attendees tuned into their screens, Dr. Elizabeth Jaffee began her presentation Pancreatic Cancer Is PRIMED to Become an Immunologic Disease. With a full house of Zoomers, the Deputy Director of…
Meenhard Herlyn, D.V.M., D.Sc., is known internationally as one of the fathers of melanoma research. As the founder of The Wistar Institute Melanoma Research Center, he has led the way with breakth…
